1-butyl-2,3-dimethylimidazolium chloride

We are 1-butyl-2,3-dimethylimidazolium chloride CAS:98892-75-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


English Name: 1-butyl-2,3-dimethylimidazolium chloride
Synonyms:1-butyl-2,3-dimethylimidazolium chloride
Molecular Formula: C9H17ClN2
Molecular Weight: 188.70
CAS No.: 98892-75-2
Purity: 99%
 
Technical Information

Appearance: Purity:
NMR: Passed null
Solubility: Insolubility:
Impurity content:
(1) dimethylimidazole content: < 1000 ppm;
(2)   Water content: < 1000 ppm

 
Physics-Chemistry Properties

Melting point: 100℃ Decomposition temperature: 257℃
Conductivity: Electrochemical window:
Viscosity: Density:

 
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts
1-butyl-2,3-dimethylimidazolium chloride


Related News: Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.N- (2'-Cianobifenil-4-ilmetil) -L-valina Clorhidrato de éster metílico CAS:482577-59-3 In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.Tetrabenzyl Pyrophosphate Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.4-Bromo-3-chlorobenzotrifluoride The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China.From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.

Related Products
Product Name
CAS:2553-19-7 Dow Corning 1-6533 View Details
HC Blue 12 View Details
4-TERT-BUTYLCATECHOL Cas:98-29-3 View Details
Ethylhexylglycerin Cas:70445-33-9 manufacturer Vinyltriethoxysilane Cas:78-08-0 manufacturer Titanium dioxide,nanometre Cas:13463-67-7 manufacturer 2-Ethoxy-1-[[2′-[(hydroxyamino)iminomethyl][1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid methyl ester manufacturer 2′-deoxyuridine manufacturer